Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 1;24(1):230.
doi: 10.1186/s12887-024-04718-x.

Next-generation sequencing based newborn screening and comparative analysis with MS/MS

Guosong Shen  1 , Wenwen Li  2 , Yaqin Zhang  2 , Lyuyan Chen  3
Affiliations

Next-generation sequencing based newborn screening and comparative analysis with MS/MS

Guosong Shen et al. BMC Pediatr. .

Abstract

Background: Newborn screening (NBS), such as tandem mass spectrometry (MS/MS), may yield false positive/negative results. Next-generation sequencing (NGS) has the potential to provide increased data output, efficiencies, and applications. This study aimed to analyze the types and distribution of pathogenic gene mutations in newborns in Huzhou, Zhejiang province, China and explore the applicability of NGS and MS/MS in NBS.

Methods: Blood spot samples from 1263 newborns were collected. NGS was employed to screen for pathogenic variants in 542 disease-causing genes, and detected variants were validated using Sanger sequencing. Simultaneously, 26 inherited metabolic diseases (IMD) were screened using MS/MS. Positive or suspicious samples identified through MS/MS were cross-referenced with the results of NGS.

Results: Among all newborns, 328 had no gene mutations detected. NGS revealed at least one gene mutation in 935 newborns, with a mutation rate of 74.0%. The top 5 genes were FLG, GJB2, UGT1A1, USH2A, and DUOX2. According to American College of Medical Genetics guidelines, gene mutations in 260 cases were classified as pathogenic or likely pathogenic mutation, with a positive rate of 20.6%. The top 5 genes were UGT1A1, FLG, GJB2, MEFV, and G6PD. MS/MS identified 18 positive or suspicious samples for IMD and 1245 negative samples. Verification of these cases by NGS results showed no pathogenic mutations, resulting in a false positive rate of 1.4% (18/1263).

Conclusion: NBS using NGS technology broadened the range of diseases screened, and enhanced the accuracy of diagnoses in comparison to MS/MS for screening IMD. Combining NGS and biochemical screening would improve the efficiency of current NBS.

Keywords: Gene mutations; Inherited metabolic diseases; Newborn screening; Next-generation sequencing; Tandem mass spectrometry.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

References

    1. Wilcken B, Wiley V. Newborn screening. Pathology. 2008;40(2):104–15. doi: 10.1080/00313020701813743. - DOI - PubMed
    1. El-Hattab AW, Almannai M, Sutton VR. Newborn screening: history, current status, and future directions. Pediatr Clin North Am. 2018;65(2):389–405. doi: 10.1016/j.pcl.2017.11.013. - DOI - PubMed
    1. Guthrie R, Susi A. A simple phenylalanine method for detecting Phenylketonuria in large populations of Newborn infants. Pediatrics. 1963;32:338–43. doi: 10.1542/peds.32.3.338. - DOI - PubMed
    1. Millington DS, Kodo N, Norwood DL, Roe CR. Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism. J Inherit Metab Dis. 1990;13(3):321–4. doi: 10.1007/BF01799385. - DOI - PubMed
    1. Malvagia S, Forni G, Ombrone D, la Marca G. Development of strategies to decrease false positive results in Newborn Screening. Int J Neonatal Screen. 2020;6(4):84. doi: 10.3390/ijns6040084. - DOI - PMC - PubMed